To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Methionine adenosyltransferase 2A (MAT2A); protein arginine methyltransferase 5 (PRMT5); RIO kinase 1 (RIOK1); methylthioadenosine phosphorylase (

Cancer

INDICATION: Colorectal cancer

Cell culture and mouse studies suggest inhibiting the MAT2A/PRMT5/RIOK1 axis could help

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE